BrightView (BV) EVP & CLO discloses 35,000-share sale and 17,539 RSU award

Rhea-AI Filing Summary

BrightView Holdings, Inc. executive Jonathan M. Gottsegen, EVP, CLO & Corporate Secretary, reported several equity transactions in early December 2025. On December 1, 2025, he sold 35,000 shares of BrightView common stock in open-market transactions at a weighted average price of $12.62 per share, with individual trade prices ranging from $12.52 to $12.80. After these sales, and subsequent transactions, he beneficially owned 145,591 shares of common stock.

On December 1, 2025, he received a grant of 17,539 restricted stock units (RSUs) that vest in four equal annual installments beginning December 1, 2026. On December 2, 2025, 5,381 RSUs vested and converted into common shares on a one-for-one basis, and 2,748 shares were withheld to cover related tax liabilities. The filing notes that RSUs may be settled in common stock or cash and that his holdings include shares from the employee stock purchase plan and unvested restricted stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gottsegen Jonathan Mark

(Last) (First) (Middle)

C/O BRIGHTVIEW HOLDINGS, INC.

980 JOLLY ROAD, SUITE 300

(Street)

BLUE BELL PA 19422

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BrightView Holdings, Inc. [ BV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO & Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		S		35,000	D	$12.62(1)	142,958(3)	D
Common Stock	12/02/2025		M		5,381	A	(2)	148,339(3)	D
Common Stock	12/02/2025		F(4)		2,748	D	$12.78	145,591(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(5)	12/01/2025		A		17,539		(6)	(6)	Common Stock	17,539	$0	17,539	D
Restricted Stock Units	(5)	12/02/2025		M			5,381	(7)	(7)	Common Stock	5,381	$0	16,143	D

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.52 to $12.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. Reflects restricted stock units that upon vesting converted into shares of Issuer common stock on a one-for-one basis.

3. Includes shares of common stock acquired under the Issuer's employee stock purchase plan and unvested shares of restricted stock. Does not include unvested performance shares which will be reported when earned upon achievement of certain performance criteria.

4. Represents the number of shares of common stock withheld to pay the related tax liability on restricted stock units that vested on December 2, 2025.

5. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in either common stock or cash (or a combination thereof).

6. Represents a grant of time-based restricted stock units that vest in four equal annual installments beginning on December 1, 2026.

7. Represents a grant of time-based restricted stock units that vest in four equal annual installments beginning on December 2, 2025.

	/s/ Jonathan M. Gottsegen	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did BrightView (BV) report for Jonathan M. Gottsegen?

The filing reports that Jonathan M. Gottsegen sold 35,000 shares of BrightView common stock on December 1, 2025 at a weighted average price of $12.62 per share, received a grant of 17,539 restricted stock units on December 1, 2025, and had 5,381 RSUs vest and convert into shares on December 2, 2025.

What is Jonathan M. Gottsegen’s role at BrightView (BV)?

Jonathan M. Gottsegen is reported as an officer of BrightView Holdings, Inc., serving as EVP, CLO & Corporate Secretary.

How many BrightView (BV) shares does Jonathan M. Gottsegen own after these transactions?

Following the reported transactions on December 1–2, 2025, Jonathan M. Gottsegen beneficially owned 145,591 shares of BrightView common stock, held in direct ownership.

What prices were received for the BrightView (BV) share sale on December 1, 2025?

The 35,000 shares of BrightView common stock sold on December 1, 2025 were executed at a weighted average price of $12.62 per share, with individual trade prices ranging from $12.52 to $12.80.

How do the new BrightView (BV) restricted stock units vest for Jonathan M. Gottsegen?

The 17,539 restricted stock units granted on December 1, 2025 vest in four equal annual installments, beginning on December 1, 2026. Another RSU grant related to the 5,381 vested units vests in four equal annual installments beginning on December 2, 2025.

Why were 2,748 BrightView (BV) shares withheld on December 2, 2025?

The filing states that 2,748 shares of BrightView common stock were withheld on December 2, 2025 to pay the related tax liability on restricted stock units that vested on that date.

What does each BrightView (BV) restricted stock unit represent in this Form 4?

Each restricted stock unit represents a contingent right to receive one share of BrightView common stock, and the RSUs will be settled in either common stock or cash, or a combination of both.